论文部分内容阅读
８０例急性腹泻病人随机分成硫酸镁注射液（ＩＭＳ）组和阿托品组（各４０例），并对ＩＭＳ与阿托品治疗急性腹泻的临床情况进行比较分析。结果发现：ＩＭＳ比阿托品的疗效更加显著（Ｐ＜０．０１），ＩＭＳ还可显著缩短病程（Ｐ＜０．０５），减少低钾或低镁及心律失常的发生。未观察到ＩＭＳ的明显不良反应。提示ＩＭＳ是治疗急性腹泻的一种有效药物。
Eighty patients with acute diarrhea were randomly divided into two groups: the magnesium sulfate injection (IMS) group and the atropine group (40 cases each). The clinical data of IMS and atropine in treating acute diarrhea were compared and analyzed. The results showed that the therapeutic effect of IMS was more significant than that of biatropine (P <0.01). IMS also significantly shortened the course of disease (P <0.05) and decreased the incidence of hypokalemia or hypocalmagination and arrhythmia. No significant adverse effects of IMS were observed. Tip IMS is an effective drug for the treatment of acute diarrhea.